diabetes

J&J’s Pump Automatically Adjusts Insulin for Diabetics
Bloomberg
Sat, 06/22/13 - 10:27 am
J&J
insulin pump
devices
diabetics
diabetes
J&J’s Pump Automatically Adjusts Insulin for Diabetics
Bloomberg
Sat, 06/22/13 - 10:05 am
diabetes
insulin pump
10 Top-selling Diabetes Drugs - 2012
Fierce Pharma
Fri, 06/21/13 - 09:26 am
diabetes
Merck
Januvia
Lantus
Sanofi
NovoRapid
Novo Nordisk
Eli Lilly
Humalog
Victoza
Levemir
Janumet
Novo Mix 30
Takeda
Actos
Summer Street 'much more optimistic' about MannKind approval
The Fly on the Wall
Fri, 06/21/13 - 09:15 am
MannKind
drug approvals
Afrezza
diabetes
AstraZeneca, Bristol diabetes drug disappoints in key test
Reuters
Wed, 06/19/13 - 10:28 am
Bristol-Myers Squibb
AstraZeneca
diabetes
Onglyza
AstraZeneca signs obesity and diabetes pact with NGM
Pharma Times, UK
Mon, 06/17/13 - 09:41 am
NGM Biopharmaceuticals
AstraZeneca
obesity
diabetes
Lilly to take over development of potential diabetes treatment from Transition Therapeutics
Yahoo/AP
Mon, 06/17/13 - 09:30 am
Eli Lilly
diabetes
Transition Therapeutics
TT-401
Novo Nordisk shares hit by concerns over rival diabetes drugs
Reuters
Mon, 06/17/13 - 09:17 am
diabetes
Novo Nordisk
Sanofi
Eli Lilly
dulaglutide
Victoza
Lyxumia
Lantus
Derma Sciences reports positive results from Phase 1 diabetic foot ulcer study
Yahoo/TheFlyOnTheWall
Fri, 06/14/13 - 11:29 am
Derma Sciences
diabetes
study
devices
research
Bristol-Myers, AstraZeneca to present 33 abstracts at ADA Scientific Sessions
Yahoo/Fly on the Wall
Fri, 06/14/13 - 10:26 am
diabetes
Bristol-Myers Squibb
AstraZeneca
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
FDA
diabetes
Merck
Januvia
Onglyza
Bristol-Myers Squibb
Byetta
AstraZeneca
Eli Lilly
Novo Nordisk
Victoza
Tradjenta
Boehringer Ingelheim
Can Mannkind Deliver A Summer Blockbuster?
Seeking Alpha
Tue, 06/11/13 - 09:16 am
MannKind
diabetes
Afrezza
Sanofi steps up diabetes drive as rivals raise the stakes
Reuters
Fri, 06/7/13 - 09:18 am
Sanofi
diabetes
Novo Nordisk
FDA Advisory Panel Backs Looser Restrictions On Avandia
Forbes
Thu, 06/6/13 - 06:54 pm
FDA
Avandia
diabetes
GSK
advisory panel
U.S. FDA panel revisits Avandia, likely too late for diabetes drug
Reuters
Thu, 06/6/13 - 10:47 am
advisory panels
FDA
diabetes
GSK
Avandia
Novo Nordisk Has One of the Widest Moats in Health Care
Yahoo/Morningstar
Thu, 06/6/13 - 10:04 am
Novo Nordisk
diabetes
FDA Avandia Panel: A Twitter-Based Review
Forbes
Wed, 06/5/13 - 05:31 pm
twitter
social media
GSK
FDA
advisory panels
Avandia
diabetes
Battleground FDA: How Wednesday's Avandia Panel Could Help Shape The Future Of Diabetes
Forbes
Wed, 06/5/13 - 10:06 am
FDA
GSK
Avandia
diabetes
advisory panels
FDA panel to consider lifting restrictions on Avandia based on new heart risk analysis
Yahoo/AP
Mon, 06/3/13 - 10:11 am
FDA
Avandia
GSK
diabetes
Doctor’s Doubts Imperil Lucrative Diabetes Drugs
NY Times, NY
Thu, 05/30/13 - 04:51 pm
physicians
diabetes
Bristol-Myers Squibb
Byetta
Merck
AstraZeneca
Januvia
Novo Nordisk
Eli Lilly
Takeda
Boehringer Ingelheim

Pages